Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Globus Medical Inc
(NY:
GMED
)
80.88
-1.09 (-1.33%)
Official Closing Price
Updated: 7:00 PM EST, Nov 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Globus Medical Inc
< Previous
1
2
3
4
5
6
Next >
Despite its growth, NYSE:GMED remains within the realm of affordability.
November 07, 2024
GLOBUS MEDICAL INC - A (NYSE:GMED) stands out as a growth opportunity that won't break the bank.
Via
Chartmill
What 7 Analyst Ratings Have To Say About Globus Medical
November 06, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 06, 2024
Via
Benzinga
CVS Health, Johnson Controls And 3 Stocks To Watch Heading Into Wednesday
November 06, 2024
Via
Benzinga
Globus Medical (GMED) Q3 2024 Earnings Call Transcript
November 05, 2024
GMED earnings call for the period ending September 30, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
The Analyst Verdict: Globus Medical In The Eyes Of 7 Experts
October 14, 2024
Via
Benzinga
NYSE:GMED is showing good growth, while it is not too expensive.
October 02, 2024
In the world of growth stocks, NYSE:GMED shines as a value proposition.
Via
Chartmill
Looking Into Globus Medical's Recent Short Interest
September 06, 2024
Via
Benzinga
A Glimpse Into The Expert Outlook On Globus Medical Through 8 Analysts
August 28, 2024
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
September 23, 2024
Via
Benzinga
While growth is established for NYSE:GMED, the stock's valuation remains reasonable.
September 11, 2024
While growth is established for NYSE:GMED, the stock's valuation remains reasonable.
Via
Chartmill
Investors should take note of NYSE:GMED, a growth stock that remains attractively priced.
August 21, 2024
GLOBUS MEDICAL INC - A (NYSE:GMED) stands out as a growth opportunity that won't break the bank.
Via
Chartmill
Looking Into Globus Medical's Recent Short Interest
August 19, 2024
Via
Benzinga
What 8 Analyst Ratings Have To Say About Globus Medical
August 07, 2024
Via
Benzinga
Globus Medical (GMED) Q2 2024 Earnings Call Transcript
August 06, 2024
GMED earnings call for the period ending June 30, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
NYSE:GMED is showing decent growth, but is still valued reasonably.
July 31, 2024
NYSE:GMED, a growth stock which is not overvalued.
Via
Chartmill
Peering Into Globus Medical's Recent Short Interest
July 25, 2024
Via
Benzinga
Where Globus Medical Stands With Analysts
July 15, 2024
Via
Benzinga
GMED Stock Earnings: Globus Medical Beats EPS, Beats Revenue for Q2 2024
August 06, 2024
GMED stock results show that Globus Medical beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
For those who appreciate growth without the sticker shock, NYSE:GMED is worth considering.
July 09, 2024
GLOBUS MEDICAL INC - A (NYSE:GMED) is showing decent growth, but is still valued reasonably.
Via
Chartmill
Staar Surgical Stock Earns RS Rating Upgrade
June 27, 2024
On Thursday, lens maker Staar Surgical stock had its Relative Strength (RS) Rating upgraded to 87 from 77.
Via
Investor's Business Daily
NYSE:GMED is not too expensive for the growth it is showing.
June 18, 2024
Looking for growth without the hefty price tag? Consider NYSE:GMED.
Via
Chartmill
Soft Inflation Data Boosts Small Caps, Real Estate, Regional Banks; Traders Anticipate Fed Rate Cuts As Stocks React
June 12, 2024
U.S. inflation slowed in May, boosting rate cut prospects. Markets rally ahead of FOMC meeting and assign 70% chance of rate cut in September.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Deep Dive Into Globus Medical Stock: Analyst Perspectives (7 Ratings)
May 29, 2024
Via
Benzinga
Key Takeaways From Globus Medical Analyst Ratings
May 09, 2024
Via
Benzinga
Stryker Stock Sees RS Rating Treks Higher To 71
May 29, 2024
Stryker stock saw a positive improvement to its Relative Strength (RS) Rating on Wednesday, with an increase from 63 to 71.
Via
Investor's Business Daily
CrowdStrike To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Wednesday
May 29, 2024
Via
Benzinga
Don't overlook NYSE:GMED—a stock with solid growth prospects and a reasonable valuation.
May 27, 2024
Looking for growth without the hefty price tag? Consider GLOBUS MEDICAL INC - A (NYSE:GMED).
Via
Chartmill
This Micron Technology Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Today
May 20, 2024
Via
Benzinga
Globus Medical Shares Race Higher After Better-Than-Expected Q1 Results
May 08, 2024
Globus Medical reported quarterly earnings of 72 cents per share which beat the analyst consensus estimate of 57 cents by 26.32% and represents a 35.85% increase over earnings from the same period last...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.